Copyright
©The Author(s) 2015.
World J Orthop. Dec 18, 2015; 6(11): 977-982
Published online Dec 18, 2015. doi: 10.5312/wjo.v6.i11.977
Published online Dec 18, 2015. doi: 10.5312/wjo.v6.i11.977
Table 2 Differences between the groups following surgery
| Control group(n = 100) | TXA group(n = 100) | P value | |
| Post-operative Hgb | 10.82 ± 1.55 | 11.33 ± 1.27 | 0.01 |
| Post-operative Hct | 0.32 ± 0.05 | 0.34 ± 0.04 | 0.01 |
| Post-operative platelets | 204.32 ± 44.68 | 212.22 ± 52.49 | 0.25 |
| Mean length of stay in hospital in days | 6.53 ± 5.92 | 5.47 ± 4.26 | 0.15 |
- Citation: McGoldrick NP, O’Connor EM, Davarinos N, Galvin R, Quinlan JF. Cost benefit analysis of the use of tranexamic acid in primary lower limb arthroplasty: A retrospective cohort study. World J Orthop 2015; 6(11): 977-982
- URL: https://www.wjgnet.com/2218-5836/full/v6/i11/977.htm
- DOI: https://dx.doi.org/10.5312/wjo.v6.i11.977